Corrigendum to “Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy” [Volume 10, Issue 1, January 2025, Pages 217-226] - Hiddo J.L. Heerspink; Meg Jardine; Donald E. Kohan; Richard A. Lafayette; Adeera Levin; Adrian Liew; Hong Zhang; Irene Noronha; Hernan Trimarchi; Fan Fan Hou; Ronny Renfurm; Todd Gray; et al. (Kidney International Reports)